Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease - PCCEI - Pathogenesis and Control of Chronic and Emerging Infections
Article Dans Une Revue Journal of Experimental Medicine Année : 2024

Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease

1 Equipe Inserm U1163 - Human genetics of infectious diseases : Mendelian predisposition
2 Hôpital Necker - Enfants Malades [AP-HP]
3 Imagine - U1163 - Imagine - Institut des maladies génétiques (IHU)
4 St. Giles Laboratory of Human Genetics of Infectious Diseases
5 EFS - Etablissement Français du Sang [La Plaine Saint-Denis]
6 UNSW - University of New South Wales [Sydney]
7 IRCCS "San Matteo" Hospital Foundation [Pavie, Italie]
8 AOUB - IRCCS Azienda Ospedaliero-Universitaria di Bologna
9 UNIBO - Alma Mater Studiorum Università di Bologna = University of Bologna
10 UNIPV - Università degli Studi di Pavia [Italia] = University of Pavia [Italy] = Université de Pavie [Italie]
11 Fondazione IRCCS Policlinico San Matteo [Pavia]
12 ASST Fatebenefratelli-Sacco [Milan, Italy]
13 Rockefeller University [New York]
14 BNITM - Bernhard Nocht Institute for Tropical Medicine - Bernhard-Nocht-Institut für Tropenmedizin [Hamburg, Germany]
15 University of Hamburg
16 Massachusetts General Hospital [Boston]
17 HMS - Harvard Medical School [Boston]
18 Garvan Institute of medical research
19 ETH Zürich - Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology [Zürich]
20 IRBA - Institut de Recherche Biomédicale des Armées [Antenne Marseille]
21 UVE - Unité des Virus Emergents
22 Hôpital Saint Philibert [Lomme]
23 UNSW - The Kirby Institute for Infection and Immunity in Society
24 National center for public health [Hungary]
25 PCCEI - Pathogenesis and Control of Chronic and Emerging Infections
26 HHMI - Howard Hughes Medical Institute
Charles M Rice
Marianna Agudelo
Emilie Duburcq-Gury
Anna Nagy
Margaret M Macdonald

Résumé

Arboviral diseases are a growing global health concern. Pre-existing autoantibodies (auto-Abs) neutralizing type I interferons (IFNs) can underlie encephalitis due to West Nile virus (WNV) (∼40% of patients) and tick-borne encephalitis (TBE, due to TBE virus [TBEV]) (∼10%). We report here that these auto-Abs can also underlie severe forms of rarer arboviral infections. Auto-Abs neutralizing high concentrations of IFN-α2, IFN-β, and/or IFN-ω are present in the single case of severe Powassan virus (POWV) encephalitis studied, two of three cases of severe Usutu virus (USUV) infection studied, and the most severe of 24 cases of Ross River virus (RRV) disease studied. These auto-Abs are not found in any of the 137 individuals with silent or mild infections with these three viruses. Thus, auto-Abs neutralizing type I IFNs underlie an increasing list of severe arboviral diseases due to Flaviviridae (WNV, TBEV, POWV, USUV) or Togaviridae (RRV) viruses transmitted to humans by mosquitos (WNV, USUV, RRV) or ticks (TBEV, POWV).
Fichier principal
Vignette du fichier
JEM_20240942.pdf (1.7 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04816089 , version 1 (03-12-2024)

Licence

Identifiants

Citer

Adrian Gervais, Paul Bastard, Lucy Bizien, Céline Delifer, Pierre Tiberghien, et al.. Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease. Journal of Experimental Medicine, 2024, 221 (12), pp.e20240942. ⟨10.1084/jem.20240942⟩. ⟨hal-04816089⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More